MedPath

Acitretin

Generic Name
Acitretin
Brand Names
Soriatane
Drug Type
Small Molecule
Chemical Formula
C21H26O3
CAS Number
55079-83-9
Unique Ingredient Identifier
LCH760E9T7

Overview

An oral retinoid effective in the treatment of psoriasis. It is the major metabolite of etretinate with the advantage of a much shorter half-life when compared with etretinate.

Background

An oral retinoid effective in the treatment of psoriasis. It is the major metabolite of etretinate with the advantage of a much shorter half-life when compared with etretinate.

Indication

For the treatment of severe psoriasis in adults.

Associated Conditions

  • Keratinization disorders
  • Severe Psoriasis

FDA Approved Products

ACITRETIN
Manufacturer:Sigmapharm Laboratories, LLC
Route:ORAL
Strength:17.5 mg in 1 1
Approved: 2023/01/10
NDC:42794-081
ACITRETIN
Manufacturer:Bryant Ranch Prepack
Route:ORAL
Strength:10 mg in 1 1
Approved: 2024/01/25
NDC:72162-2222
Acitretin
Manufacturer:Mylan Pharmaceuticals Inc.
Route:ORAL
Strength:10 mg in 1 1
Approved: 2022/03/15
NDC:0378-7020
Acitretin
Manufacturer:Amneal Pharmaceuticals of New York LLC
Route:ORAL
Strength:10 mg in 1 1
Approved: 2023/12/30
NDC:0115-1750
ACITRETIN
Manufacturer:AvKARE
Route:ORAL
Strength:17.5 mg in 1 1
Approved: 2024/01/09
NDC:42291-087

Singapore Approved Products

ACITRET CAPSULE 25MG
Manufacturer:USV Private Limited
Form:CAPSULE
Strength:25.00mg
Online:Yes
Approved: 2023/08/04
Approval:SIN16829P

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath